ArticleProbiotics and antimicrobial proteins2025
Bacillus velezensis FiA2 as an Oxydifficidin-Producing Strain and its Effects on the Growth Performance, Immunity, Intestinal Microbiota, and Resistance to Aeromonas salmonicida Infection in Carassius carassius.
Article in Probiotics and antimicrobial proteins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Dietary pyrroloquinoline quinone alleviated intestinal damage of juvenile yellow catfish (Pelteobagrus fulvidraco) induced by oxidized fish oil: insight from intestinal digestive enzyme, antioxidant status, morphology, inflammation, and microbiota.Fish physiology and biochemistry · 2026Article
- The Invisible Balance: How Prebiotics and Probiotics Can Support Fish Health and Development.Life (Basel, Switzerland) · 2026Review
- Research Progress on the Effect ofCurrent issues in molecular biology · 2026Review
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
Abstract
In aquaculture, biological control of bacterial infections is a promising strategy that, aside from preventing infections, also benefits the host in several ways. In this study, a Bacillus strain FiA2 isolated from the gut of Carassius carassius (crucian carp) exhibited broad spectrums of activity against multiple aquatic bacterial pathogens. The compound with antibacterial activity was successfully separated and identified as oxydifficidin, with a m/z of 559.47. The oxydifficidin retained its activity even after being exposed to high temperatures, ultraviolet light, proteolytic enzymes, chemical reagents, and alkaline and acidic pH. Furthermore, crucian carp, when supplemented with FiA2 in diet, reduced the infection rate (post-challenged survival rate of 45%), increased the total weight gain by 15.87%, and upregulated the mRNA levels of IGF-1 and IGF-2 (P < 0.05) of muscular tissues. Similarly, the innate immune-related genes in the liver, the spleen, and the head kidney of the fish in the FiA2-supplemented group were significantly upregulated (P < 0.05). In addition, FiA2 modulated the intestinal microbiota, as observed in the FiA2 group of crucian carp; the predominant phyla were Actinobacteriota and Firmicutes, whereas in the control group, Plesiomonas dominated at the genus level. Overall, we conclude that B. velezensis FiA2, a broad-spectrum oxydifficidin-producing strain, resists infection and positively regulates the growth, immunity, and intestinal microbiota of crucian carp and thus can be implemented as a novel probiotic strain for aquaculture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.